Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

31
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
31
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

25
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same author

Molecular-Anion Interfacial Engineering for Solid Electrolyte Interphase to Obtain High-Performance Aqueous Zinc-Ion Batteries.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

NIR-II Light-Modulated Smart Drug Delivery System Utilizing Drug-Gated Nanocomposite Hydrogel for Boosting Anticancer Efficacy.

Polymer science & technology (Washington, D.C.)·2026
Same author

Synthetic Polymers for Drug, Gene, and Vaccine Delivery.

Polymer science & technology (Washington, D.C.)·2026
Same author

Clinically oriented deep learning system integrating linear and morphological assessment for external orthodontic root resorption.

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics·2026
Same author

Activatable Polymeric STING Agonist-Gold Nanorod Conjugate Driving STING Signaling and Immunogenic Activation in Colorectal Cancer Immunotherapy.

Nano letters·2026

Related Experiment Video

Updated: Feb 18, 2026

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
07:47

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

9.5K

Injectable Thermosensitive Polypeptide-Based CDDP-Complexed Hydrogel for Improving Localized Antitumor Efficacy.

Shuangjiang Yu1,2, Dianliang Zhang1,3, Chaoliang He1

  • 1Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences , Changchun 130022, China.

Biomacromolecules
|November 17, 2017
PubMed
Summary
This summary is machine-generated.

A novel thermosensitive polypeptide hydrogel improves cisplatin (CDDP) delivery for cancer therapy. This injectable hydrogel offers sustained drug release, enhanced antitumor effects, and good biocompatibility in vivo.

More Related Videos

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.9K
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

12.0K

Related Experiment Videos

Last Updated: Feb 18, 2026

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance
07:47

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

9.5K
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

8.9K
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
09:30

The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications

Published on: October 7, 2016

12.0K

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Cancer Therapy

Background:

  • Conventional chemotherapy faces challenges like burst drug release and systemic toxicity.
  • Developing advanced drug delivery systems is crucial for improving localized cancer treatment efficacy.
  • Thermosensitive hydrogels offer potential for controlled release of chemotherapeutic agents.

Purpose of the Study:

  • To develop a novel thermosensitive polypeptide-based hydrogel for improved cisplatin (CDDP) delivery.
  • To investigate the effect of carboxyl group content on hydrogel properties and CDDP release.
  • To evaluate the in vivo antitumor efficiency and biocompatibility of the developed hydrogel system.

Main Methods:

  • Synthesis of methoxy-poly(ethylene glycol)-b-(poly(γ-ethyl-l-glutamate-co-l-glutamic acid) (mPEG-b-P(ELG-co-LG)) hydrogels with varying carboxyl group content.
  • Complexation of cisplatin (CDDP) with the carboxyl groups of the polypeptide hydrogel.
  • In vitro characterization of hydrogel properties, including gelation behavior, mechanical properties, and drug release kinetics.
  • In vitro cytotoxicity and IC50 assessment of CDDP-complexed hydrogel.
  • In vivo evaluation of hydrogel biocompatibility and antitumor efficacy in a tumor model.

Main Results:

  • A thermosensitive polypeptide hydrogel with tunable gelation was successfully developed.
  • Carboxyl group incorporation reduced burst release of CDDP through complexation.
  • The mPEG-b-P(ELG-co-LG) hydrogel demonstrated good in vivo biocompatibility and biodegradability.
  • CDDP-complexed hydrogel showed significantly enhanced in vivo antitumor efficacy compared to non-complexed hydrogel.
  • In vitro studies indicated lower cytotoxicity and IC50 for the CDDP-complexed hydrogel.

Conclusions:

  • The developed injectable CDDP-complexed polypeptide hydrogel is a promising platform for localized tumor therapy.
  • The tunable nature of the hydrogel allows for controlled release and improved therapeutic outcomes.
  • This approach enhances antitumor efficiency while maintaining good biocompatibility.